Processa Pharmaceuticals, Inc. Contractual Obligation
Processa Pharmaceuticals, Inc. (PCSA) had Contractual Obligation of $487.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-06.
Discontinued › Notes › Commitment and Contingencies
us-gaap:ContractualObligation · last filed 2020-03-06
- 2019-12-31: Contractual Obligation $487.00K.
- 2018-09-30: Contractual Obligation $1.80M.
- 2018-05-25: Contractual Obligation $82.50K.
| Period end | Contractual Obligation |
|---|---|
| 2019-12-31 | $487.00K 10-K · filed 2020-03-06 |
| 2018-09-30 | $1.80M 10-Q · filed 2018-11-14 |
| 2018-05-25 | $82.50K 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |